3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Rectal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Sarcoma
8
Stomach Neoplasms
7
Esophageal Neoplasms
7
Breast Neoplasms
7
Neoplasms
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Carcinoma, Hepatocellular
5
Recurrence
4
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Thyroid Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Glioma
3
Glioblastoma
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Mouth Neoplasms
2
Hyperthermia
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Interventions
Diathermy
10
Radiotherapy
6
Surgical Procedures, Operative
2
Solutions
2
Hyperthermia, Induced
2
Hydrogen Peroxide
2
Drug Therapy
2
Brachytherapy
2
tislelizumab
1
anlotinib
1
Temozolomide
1
Saline Solution
1
Radiation
1
Patient Reported Outcome Measures
1
Immunotherapy
1
Immune Checkpoint Inhibitors
1
Ifosfamide
1
Folfox protocol
1
Fluorouracil
1
Doxorubicin
1
Dacarbazine
1
Consolidation Chemotherapy
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Hyperthermia
×
Surgical Procedures, Operative
×
Clear all
NCT06835049
2025-12-30
TNT-HYPE
Swiss Cancer Institute
Phase 2
Recruiting
24 enrolled
NCT05099809
2024-09-19
RESHMART
Mahatma Gandhi Institute of Medical Sciences
Recruiting
500 enrolled